Skip to main content
. 2013 Nov 28;9(2):443–449. doi: 10.3892/mmr.2013.1834

Figure 5.

Figure 5

Expression of (A and B) VEGF, (C and D) VEGFR2, and (E and F) bFGF using immunohistochemical analysis (x200). (A, C and E) Control groups. (B, D and F) VPA-treated groups. VEGF, vascular endothelial growth factor; bFGF, basic fibroblast growth factor; VPA, valproic acid; VEGFR-2, VEGF receptor-2.